Clinical Trial Update: Evaluation of BH4 Responsiveness in Our PKU Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating BH4 (tetrahydrobiopterin) responsiveness in phenylketonuria patients; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• tetrahydrobiopterin (tetrahydrobiopterin)

Snippet

Sponsor: Sohag University | Conditions: Phenylketonuria (PKU) | Phase 1 | Status: ACTIVE_NOT_RECRUITING